Navigation Links
Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
Date:7/16/2008

lopment programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By engineering ZFPs that recognize a specific DNA sequence Sangamo has created ZFP transcription factors (ZFP TF(TM)) that can control gene expression and, consequently, cell function. Sangamo is also developing sequence-specific ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo has established strategic partnerships with companies outside of the human therapeutic space including Dow AgroSciences, Sigma-Aldrich Corporation and several companies applying its ZFP Technology to enhance the production of protein pharmaceuticals. For more information about Sangamo, visit the company's web site at http://www.sangamo.com.

This press release contains forward-looking statements regarding Sangamo's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include the early stage of ZFP Therapeutic development, uncertainties related to the timing of initiation and completion of clinical trials, and whether clinical trial results will validate and support the safety and efficacy of ZFP Therapeutics. Further, there can be no assurance that the necessary regulatory approvals will be obtained or that Sangamo will be able to develop commercially viable gene based therapeutics. Actual results may differ from those projected in forward-looking statements due to risks and uncertainties that exist in the company's operations and business environments. These risks and uncertainties are described more fully in the company's' Annual Reports on Form 10-K and Quarterly Repo
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sangamo BioSciences Presents Data Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
3. Sangamo BioSciences to Present at the 2007 BIO InvestorForum
4. Sangamo BioSciences Announces Third Quarter 2007 Conference Call and Webcast
5. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
6. Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
7. Sangamo BioSciences to Present at the BMO Capital Markets Health Care Conference
8. Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
9. Sangamo BioSciences Announces Fourth Quarter and Year-End 2007 Conference Call and Webcast
10. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).../ - Microbix Biosystems Inc. (the "Company") annou...Certification of Annual Filings of William Gastle,...hief Financial Officer (the "Officer,s Certificate...annual audited financial statements for the year e...ly filed the annual financial statements for the y...
(Date:11/6/2009)... Myriant Technologies LLC ("Myriant"), a privately...wable bio-chemicals, Uhde Corporation of America a...e of the world,s leading engineering contractors (...ineering, procurement & construction (EPC) of ...enewable feedstocks. The execution of this allian...
(Date:11/6/2009)...wire/ -- Calbiotech, Inc. announced today that it ...rch (SBIR) Phase I contract by the U.S. Army Medic...he agreement, Calbiotech will develop analyte spec...irus. ,, Dengue virus is a mosquito-born fla... forces deployed to tropical areas of the world. D...
(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...- Third Quarter 2007 Financial Results and Busines...0 a.m. Eastern Time -, OAKLAND, Calif., Nov. 14 ..., a developer of mechanical circulatory,support sy...l results and,host a presentation of the results a....m. Pacific / 11:30 a.m. Eastern time on November,...
...MELBOURNE, Australia, Nov. 14 Swiss experts have,...st (TST) favouring the,use of interferon-a release...or screening patients for tuberculosis (TB) infect...h as anti-TNF-a therapy). In recommendations,publi...kly, experts,advocate the use of QFT(TM) in place ...
...NEW HAVEN, CT, and TORONTO, Nov. 13 /PRNewswire/ -...nt of RiboSwitch based therapeutic agents and,Dalt...esearch collaboration,to discover new therapeutics...roprietary insights to,design and synthesize sever...oSwitch targets. BioRelix will advance these compo...
Other Biology Technology:Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy 2Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy 3BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology 2
(Date:11/5/2009)...archers at Yale University have developed syntheti... response to HIV and HIV-infected cells, as well a...hed online in the Journal of the American Chemica...ches for these diseases. , The molecules calle...M-H) and "antibody-recruiting molecule targeting p...
(Date:11/4/2009)...in natural science) , United States Using Less...r today than it did 35 years ago, despite a 30 per...e partly attributable to alternative cooling metho...ystems. According to the latest USGS water use rep...tates goes to cooling thermoelectric power plants....
(Date:11/4/2009)...y bacteria, it turns out, hold the power to help m...d the world clean up toxic waste on test sites. ,... were invented back in World War II and have been ...h-energy compounds are often used to propel tank s... , But with increased knowledge of their envir...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Gloomy Days Dim Cognitive Powers of the Depressed 52961 1Gloomy Days Dim Cognitive Powers of the Depressed 52961 2
..., London, UK, 9 June 2008 Elsevier, a world-lead... information products and services, is pleased to ...( http://www.sciencedirect.com/science/journal/175...opics throughout the life sciences. , The aim of ... work that is interesting and challenging, and pro...
..., This release is available in Spanish . , , ...to monitor radioactivity levels in the environment...ended by Ms Natalia Alegra at the University of ...gy for distinguishing between natural radioactivit... Most countries currently have radiological monit...
..., (PHILADELPHIA) A clinical study on patients wh...lly purified extract of Chinese red yeast rice, Xu...ttacks by 45%, revascularization (bypass surgery/a...rtality by one-third and cancer mortality by two-t...tudy, was conducted on almost 5,000 patients, rang...
Other Biology News:Elsevier launches Bioscience Hypotheses 2More sensitive radiology monitoring in the Basque Country 2More sensitive radiology monitoring in the Basque Country 3Study finds Chinese food good for your heart 2
RNase H from Roche Applied Science
T4 DNA Ligase (HC) from Invitrogen
Sheep Anti-Bovine BETA-LACTOGLOBULIN A Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Somatostatin 28 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: